Infección urinaria recurrente | 07 OCT 18

Resistencia en uropatógenos, profilaxis antibiótica

Los niños con reflujos vesicoureterales (RVU) deberían ser manejados con profilaxis antibiótica continua con el objetivo de prevenir las infecciones urinarias (ITUs) recurrentes.
Autor/a: Rachel E. Selekman, Daniel J. Shapiro, John Boscardin, y colaboradores  Fuente: PEDIATRICS Vol. 142 No. 1 July 01, 2018 e20180119 Uropathogen Resistance and Antibiotic Prophylaxis: A Meta-analysis
INDICE:  1. Página 1 | 2. Página 2
Página 2

REFERENCES

1. Downs SM. Technical report: urinary tract infections in febrile infants and young children. The urinary tract Subcommittee of the American Academy of Pediatrics Committee on Quality Improvement. Pediatrics. 1999;103(4). Available at: www.pediatrics. org/cgi/content/full/103/4/e54

2. Elder JS, Peters CA, Arant BS Jr, et al. Pediatric vesicoureteral reflux guidelines panel summary report on the management of primary vesicoureteral reflux in children. J Urol. 1997;157(5):1846–1851

3. Edlin RS, Copp HL. Antibiotic resistance in pediatric urology. Ther Adv Urol. 2014;6(2):54–61

4. Cheng CH, Tsai MH, Huang YC, et al. Antibiotic resistance patterns of community-acquired urinary tract infections in children with vesicoureteral reflux receiving prophylactic antibiotic therapy. Pediatrics. 2008;122(6):1212–1217

5. Conway PH, Cnaan A, Zaoutis T, Henry BV, Grundmeier RW, Keren R. Recurrent urinary tract infections in children: risk factors and association with prophylactic antimicrobials. JAMA. 2007;298(2):179–186

6. Moher D, Liberati A, Tetzlaff J, Altman DG; PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med. 2009;151(4):264–269, W64

7. Wang H-HS, Gbadegesin RA, Foreman JW, et al. Efficacy of antibiotic prophylaxis in children with vesicoureteral reflux: systematic review and meta-analysis. J Urol. 2015;193(3):963–969

8. Nagler EVT, Williams G, Hodson EM, Craig JC. Interventions for primary vesicoureteric reflux. Cochrane Database Syst Rev. 2011;(6): CD001532

9. Fenton JJ, Mirza SK, Lahad A, Stern BD, Deyo RA. Variation in reported safety of lumbar interbody fusion: influence of industrial sponsorship and other study characteristics. Spine. 2007;32(4): 471–480

10. Magiorakos AP, Srinivasan A, Carey RB, et al. Multidrug-resistant, extensively drug-resistant and pandrugresistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012;18(3):268–281

11. Sterne JAC, Egger M, Moher D. Addressing reporting biases. In: Higgins JPT, Green S, eds. Cochrane Handbook for Systematic Reviews of Intervention. Version 5.1.0. The Cochrane Collaboration; 2011. Available at: www.cochrane-handbook. org/. Accessed March 2011

12. Higgins JP, Savovic J, Page MJ, Sterne JA. Revised Cochrane risk of bias tool for randomized trials (RoB 2.0). 2016. Available at: https://sites.google.com/ site/riskofbiastool/RoB2-0_indiv_ parallel_cribsheet.pdf?attredirects= 0&d=1. Accessed March 6, 2016

13. Stewart GB, Altman DG, Askie LM, Duley L, Simmonds MC, Stewart LA. Statistical analysis of individual participant data meta-analyses: a comparison of methods and recommendations for practice. PLoS One. 2012;7(10):e46042–e46048

14. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7(3):177–188

15. Higgins JPT, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21(11):1539–1558 

16. Garin EH, Olavarria F, Garcia Nieto V, Valenciano B, Campos A, Young L. Clinical significance of primary vesicoureteral reflux and urinary antibiotic prophylaxis after acute pyelonephritis: a multicenter, randomized, controlled study. Pediatrics. 2006;117(3):626–632

17. Montini G, Rigon L, Zucchetta P, et al; IRIS Group. Prophylaxis after first febrile urinary tract infection in children? A multicenter, randomized, controlled, noninferiority trial. Pediatrics. 2008;122(5):1064–1071

18. Pennesi M, Travan L, Peratoner L, et al; North East Italy Prophylaxis in VUR Study Group. Is antibiotic prophylaxis in children with vesicoureteral reflux effective in preventing pyelonephritis and renal scars? A randomized, controlled trial. Pediatrics. 2008;121(6). Available at: www. pediatrics.org/cgi/content/full/121/6/ e1489

 

Comentarios

Para ver los comentarios de sus colegas o para expresar su opinión debe ingresar con su cuenta de IntraMed.

AAIP RNBD
Términos y condiciones de uso | Política de privacidad | Todos los derechos reservados | Copyright 1997-2024